L19 - Aids and Immunodeficiency Flashcards

1
Q

Immunodeficiencies: what are they and what can they cause?

A

Conditions where the body has a decreased ability to fight infections and other diseases

Immunodeficiencies can cause overactive immune responses:
* Autoinflammatory disorders
* Autoimmune disorders-defects in regulation or tolerance (covered in a previous lecture)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the stages of immunodeficiency?

A

Primary (inherited) Immunodeficiency
- defects in components of innate immunity
- defects in components of adaptive immunity

Secondary (acquired) Immunodeficiency
- HIV (AIDs)
- malnutrition, drug reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Primary immunodeficiency: what is it, how many genes result in it, what genes are they caused by, when are they normally diagnosed, and what are they grouped by?

A

Rare heterogeneous conditions that are immune-related and often lead to immunodeficiency

> 300 distinct genetic defects identified so far

Rare autosomal or x-linked recessive conditions

Normally diagnosed early in infants

Often grouped by the component of the immune system most affected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Autoinflammatory disorders: what are the examples, what are they caused by, what symptoms do they have, and what are their treatments?

A

Cryopyrin-associated periodic syndrome (CAPS)
- autosomal dominant mutations in cryopyrin (NLRP3) - recurrent episodes of fever, a hive-like rash; joint pain and swelling; red eyes; headaches, and if untreated can cause deafness or amyloidosis.

  • Familial Mediterranean fever - mutations in gene encoding the inflammasome regulator pyrin - result in recurrent fevers, inflammation of the abdomen, chest and joints and can cause amyloidosis

Treatments for both can include drugs to target interleukin-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Autoimmune disorders: what

A
  • Autoimmune syndrome (IPEX) - defects in the Foxp3 gene (Tregs)
  • Autoimmune lymphoproliferative syndrome (ALPS) - defects in Fas or FasL genes - lymphoproliferation, lymphadenopathy and splenomegaly, higher risk of lymphoma

requires monitoring and may need immunosuppressive agents e.g. if autoimmunity develops

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Immunodeficiencies: what do they most often result in, and what parts of the immune system are compromised in infections with pyogenic bacteria, fungal infections, and recurrent viral infections?

A

Main consequence of most PIDs is increased susceptibility to opportunistic infections

  • Pyogenic bacteria - antibody, complement, phagocytes
  • Fungal infections - Th17
  • Recurrent viral infections- T cells (Tc/Th1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Defects in the innate immune response: what conditions result in defects in phagocyte production, adhesion, activation, and killing?

A
  • Phagocyte production - Congenital neutropenia (e.g. CXCR4)
  • Phagocyte adhesion - Leucocyte adhesion deficiencies (LAD-1, LAD-2) - x2 neutrophil amount in circulation but less are found in inflammation than needed
  • Phagocyte activation - Defects of PRR sensing and signalling
  • Phagocyte killing: Chronic granulomatous disease (CGD) [Chediak-Higashi syndrome]
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Defects of Adaptive Immunity: how can it happen and what form of combined immunodeficiency may occur

A

Th needed for B cell activation, Ab production, isotype switching - defects in function of the T cell compartment often affect B cells too as a result

The most severe forms of combined immunodeficiency involve complete failure of T cell development– severe combined immunodeficiencies (SCID)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SCID: what is it, what mutations cause it, and what occurs within it?

A

Severe combined immune deficiency

Mutation in several different genes can cause SCID

  • Involves a block in T-cell development
  • A direct or indirect B cell deficiency
  • NK cells may also fail to develop

Leccy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Defective cytokine signalling in T cell precursors

A
  • X-linked SCID (T-B+NK- SCID) - most frequent form of SCID, mutations in the common γ chain (c), a shared component of receptors for the IL-2 cytokine family - IL2, 4, 7, 9, 15 and 21

Affects males - Also was known as ‘the bubble boy disease’

  • JAK-3 SCID (T-B+NK- SCID) - clinically and immunologically indistinguishable from X-linked SCID, not X-linked (Autosomal recessive)

IL7R SCID (T-B+NK+ SCID)

Affects only T and not NK cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Defects resulting in B cell deficiency

A

Mutations that specifically target B cells

Most common form of immunodeficiencies

N.B. Normally free of infection up to 7-9 months due to maternal antibodies

Recurrent bacterial infections, particularly encapsulated pyogenic bacterial which require opsonisation and clearance

Two broad classes:

Absence of mature B cells

Presence of mature B cells (but with some impairment of response)

Treatment with IVIG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

X-linked agammaglobulinemia (XLA)

A

Absence of mature B cells

Mutations occurs at the pre-B-cell stage resulting in arrested B cell development

Selective X-inactivation preserves the wt allele in female carriers

Profound deficiency of B cells and circulating antibodies

Recurrent pyogenic bacterial infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Presence of mature B cell with impaired function i.e. impaired antibody

A

Most common PIDs

Levesl of B cells are normal

Only some affected genes have been characterised – in most cases the genetic cause is not yet defined

Defects in Ig often limited to one or more antibody isotype

Clinically and genetically heterogeneous

Often undiagnosed until late childhood/adulthood

Typically mild recurrent infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Defects resulting in deficient T/B and T/APC communication: Hyper IgM syndromes

A

Mutation in CD40L gene
(expressed by activated T cells)

Unable to engage with CD40 on B cells and APC

Failure of B cells to undergo isotype switching

Impaired activation of macrophages and DC and production of IL12
- impaired type I immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Igs: what is the first one made in an immune response and what happens if the body’s isotype switching ability is impaired?

A

If you can’t isotype switch you will only make IgM (remember this is the first Ig we make in an immune response).

Again the key concept is because something on a T helper cells is impacted and they are central to SO many immune functions that the ipact is on B cell antibody function and macrophage/dendritic cells functions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of PIDs

A

Early intervention with antibiotics and antifungals

Replacing the missing component;
- Protein replacement: e.g. IVIG
- Cell replacement: Matched allogeneic BMT/HST e.g. SCID, LAD
- Gene replacement: Where the gene defect is known: gene therapy and autologous HST - drawbacks are the potential for insertional mutagenesis

CRISPR (Clustered regularly interspaced short palindromic repeats) now offers the opportunity to repair rather than replace defective gene

16
Q

Secondary (Acquired) Immunodeficiencies

A

Born with an intact competent immune system

Defects in the immune system acquired as a secondary
impact of an external event occurring in the life of the patient;
- malnutrition
- therapeutic immune suppression (e.g. transplantation, cancer)
- infection (e.g. HIV/AIDS)

17
Q

AIDS

A

Acquired Immune Deficiency Syndrome

Human immunodeficiency virus (HIV)- identified as the causative agent of AIDS

18
Q

HIV: what is it, what are its types, what cellls does it affect, and how dangerous is it?

A

Human immunodeficiency virus

HIV-1
* From chimpanzees
* More virulent
* Responsible for most of AIDS worldwide

HIV-2
* From sooty mangabey
* Less virulent
* Western Africa

  • Cells expressing CD4 and either a co-receptor of CCR5 or CXCR4
  • Dendritic cells
  • Monocytes/macrophages
  • Dendritic cells

The major route of entry is via mucosal surfaces of the genital and GI tract - exchange of bodily fluids

Untreated infection leads to death following a clinical latency of 7-12 years

19
Q

HIV transmission: the process behind it

A

A few viruses make it across an intact epithelial barrier - local propagation in a small number of susceptible cells at the site of entry before they transfer to draining lymph nodes where they have many T-cells to use

  • Rapid rise in viral production
  • Systemic dissemination
  • Massive killing of CD4+ memory T cells in the gut (GALT) and peak viral load in plasma

self-sustaining infection - establishment of ‘latent reservoirs’

Transmission rate is increased if the mucosal barrier is damaged

20
Q

Follicular Dendritic cells can act as viral reservoirs

A

Leccy

21
Q

Why is HIV so challenging for the body to deal with?

A
  • High replication rate
  • High mutation rate (Epitopes change by the time CTL and Abs are generated)
  • Can ‘hide’ from the immune system for long periods as a provirus (Latent reservoir)
  • Camouflages itself
  • Activation of virus-specific Cytotoxic T cells - Depletion of infected CD4 T cells (leccy?)
22
Q

HIV: the phases

A

The asymptomatic phase is dynamic;

– rapid replication of virus + activation of latent provirus

constant viral load despite active immune response

Deleted CD4 T cells are replenished from BM and redistribution and expansion of Tmem → only very slow decline

The transition to symptomatic disease - Eventually there is a collapse of CD4 counts + loss of CD4 function,

-N.B. Both impact help for CTLs and B cells

Transition from asymptomatic to symptomatic

Virus is no longer contained → increase in viral levels

Disruption of lymph node architecture;

causes release of virus trapped on follicular dendritic cells (FDC)

compromises the ability to mount any further counter immune response

23
Q

HIV: therapy

A

Antiretroviral drugs delay progression to AIDS

  • Viral protease Inhibitors
  • Reverse transcriptase inhibitors
  • Integrase inhibitor
  • Fusion inhibitor
  • Co-receptor binding inhibitors

HIV rapidly mutates to develop resistance to drugs if they used individually

24
Q

HAART

A

Highly Active Anti-Retroviral Therapy

Combination therapy

Use drugs (usually 3) targeting different mechanisms

Massively improves prospects for HIV infected patients
(a 20 yr old infected with HIV, and receiving HAART, can now expect to live a further 50 years)

Main drawbacks

Cost and availability

Active only on replicating virus, DOES NOT eliminate latent virus

Compliance (life-long treatment required)

Side-effects

Failure to maintain drug treatment allows
‘REBOUND’ of virus and return to loss of CD4+ T cell counts

HAART is NOT a sterilising cure

Reduce viral load and so decrease the chances of transmission;

Avoid vertical transmission in infected pregnant women (reduces risk from ~20% to ~1%)

Pre-exposure prophylaxis, e.g. in couples with only one infected partner

Goal of AIDS-free generation by interrupting transmission by universal access to ART for all individuals living with HIV

25
Q
A